Dexcom (DXCM) Shares Issued (2010 - 2026)

Dexcom (DXCM) has 17 years of Shares Issued data on file, last reported at $12.7 million in Q1 2026.

• Quarterly Shares Issued fell 10.56% year-over-year to $12.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.6 million (down 8.28% YoY) and the FY2025 annual result came in at $28.1 million, changed 0.35% from the prior year.
• Shares Issued declined to $12.7 million in Q1 2026 per DXCM's latest filing, from $13.9 million in the prior quarter.
• Across five years, Shares Issued topped out at $14.8 million in Q3 2024 and bottomed at $10.1 million in Q1 2022.
• The 5-year median for Shares Issued is $13.4 million (2024), against an average of $13.1 million.
• The widest annual swing landed in 2023, when Shares Issued advanced 21.78%; it then fell 10.56% in 2026.
• Tracing DXCM's Shares Issued over 5 years: stood at $12.4 million in 2022, then climbed by 15.32% to $14.3 million in 2023, then climbed by 3.5% to $14.8 million in 2024, then slipped by 6.08% to $13.9 million in 2025, then decreased by 8.63% to $12.7 million in 2026.
• Per Business Quant, the three latest DXCM Shares Issued figures stand at $12.7 million (Q1 2026), $13.9 million (Q3 2025), and $14.2 million (Q1 2025).

Peer Comparison